Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial details imported from ClinicalTrials.gov
For full trial details, please see the original record at
https://clinicaltrials.gov/ct2/show/NCT03075722
Registration number
NCT03075722
Ethics application status
Date submitted
5/03/2017
Date registered
9/03/2017
Date last updated
20/04/2017
Titles & IDs
Public title
The Evaluation of a Nasal Mask for the Treatment of Obstructive Sleep Apnea (OSA): Comfort & Performance Trial
Query!
Scientific title
The Evaluation of a Nasal Mask for the Treatment of Obstructive Sleep Apnea (OSA): Comfort & Performance Trial
Query!
Secondary ID [1]
0
0
CIA-205
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Sleep Disordered Breathing
0
0
Query!
Obstructive Sleep Apnea
0
0
Query!
Condition category
Condition code
Respiratory
0
0
0
0
Query!
Sleep apnoea
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
Treatment: Devices - Saturn nasal mask
Experimental: Saturn nasal mask - Participants to use nasal mask in-home for 7 ± 3 days
Treatment: Devices: Saturn nasal mask
Nasal mask for the treatment of obstructive sleep apnea (OSA)
Query!
Intervention code [1]
0
0
Treatment: Devices
Query!
Comparator / control treatment
Query!
Control group
Query!
Outcomes
Primary outcome [1]
0
0
Comfort
Query!
Assessment method [1]
0
0
Subjective questionnaire
Query!
Timepoint [1]
0
0
Up to 7 ± 3 days in-home
Query!
Primary outcome [2]
0
0
Stability
Query!
Assessment method [2]
0
0
Subjective questionnaire
Query!
Timepoint [2]
0
0
Up to 7 ± 3 days in-home
Query!
Primary outcome [3]
0
0
Objective leak data
Query!
Assessment method [3]
0
0
Obtained from participant's CPAP device
Query!
Timepoint [3]
0
0
Up to 7 ± 3 days in-home
Query!
Primary outcome [4]
0
0
Subjective measurement of leak
Query!
Assessment method [4]
0
0
Subjective questionnaire
Query!
Timepoint [4]
0
0
Up to 7 ± 3 days in-home
Query!
Primary outcome [5]
0
0
Draft
Query!
Assessment method [5]
0
0
Subjective questionnaire
Query!
Timepoint [5]
0
0
Up to 7 ± 3 days in-home
Query!
Primary outcome [6]
0
0
Treatment efficacy
Query!
Assessment method [6]
0
0
Obtained from participant's CPAP device
Query!
Timepoint [6]
0
0
Up to 7 ± 3 days in-home
Query!
Primary outcome [7]
0
0
Noise
Query!
Assessment method [7]
0
0
Subjective questionnaire
Query!
Timepoint [7]
0
0
Up to 7 ± 3 days in-home
Query!
Secondary outcome [1]
0
0
Preference of mask
Query!
Assessment method [1]
0
0
Subjective questionnaire
Query!
Timepoint [1]
0
0
Up to 7 ± 3 days in-home
Query!
Secondary outcome [2]
0
0
Usability
Query!
Assessment method [2]
0
0
Subjective questionnaire
Query!
Timepoint [2]
0
0
Up to 7 ± 3 days in-home
Query!
Eligibility
Key inclusion criteria
- Adult (18+ years of age)
- Able to give consent
- AHI = 5 on diagnostic night
- Prescribed a CPAP device after successful OSA diagnosis
- Existing nasal or nasal pillow mask user
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
No limit
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
- Inability to give consent
- Participants who are in a coma or a decreased level of consciousness.
- Anatomical or physiological conditions making APAP therapy inappropriate (e.g.
unconsolidated facial structure)
- Commercial drivers who are investigated by New Zealand Transport Agency (NZTA)
- Current diagnosis of CO2 retention
- Pregnant or may think they are pregnant.
Query!
Study design
Purpose of the study
Treatment
Query!
Allocation to intervention
N/A
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Query!
Masking / blinding
Open (masking not used)
Query!
Who is / are masked / blinded?
Query!
Query!
Query!
Query!
Intervention assignment
Single group
Query!
Other design features
Query!
Phase
Not Applicable
Query!
Type of endpoint/s
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Completed
Query!
Data analysis
Query!
Reason for early stopping/withdrawal
Query!
Other reasons
Query!
Date of first participant enrolment
Anticipated
Query!
Actual
9/03/2017
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
Query!
Date of last data collection
Anticipated
Query!
Actual
15/04/2017
Query!
Sample size
Target
Query!
Accrual to date
Query!
Final
14
Query!
Recruitment in Australia
Recruitment state(s)
Query!
Recruitment outside Australia
Country [1]
0
0
New Zealand
Query!
State/province [1]
0
0
Wellington
Query!
Funding & Sponsors
Primary sponsor type
Commercial sector/Industry
Query!
Name
Fisher and Paykel Healthcare
Query!
Address
Query!
Country
Query!
Ethics approval
Ethics application status
Query!
Summary
Brief summary
This investigation is designed to evaluate the performance (treatment and leak), comfort
(subjective feedback), stability (subjective feedback, leak) as well as the participant's
overall acceptance of the Saturn mask amongst OSA participants. An important factor in this
investigation will be the testing of our two different seal sizes on the participants (small
and medium size). A total number of 15 participants who currently use nasal or nasal pillow
masks will be recruited for the trial. A subset of participants have been selected based on
their anthropometric measurements collected in previous trials using nasal and nasal pillow
masks at this site (CIA-103). Participants from previous NZ trials may be recruited into this
trial with their consent. All the participants will be recruited by WellSleep, Wellington.
Participants will use the trial mask in home for a period of 7 ± 3 days. Baseline data will
be collected from the participant during the first visit, the prior 7 days of CPAP usage data
will be downloaded and stored for our analysis. The participant will use the trial device on
their usual CPAP/APAP setting and device for the duration of the trial.
This study will be conducted in accordance with ICH/GCP guidelines. No deviation from the
protocol will be implemented without prior review and approval of the sponsor except where it
may be necessary to eliminate an immediate hazard to a research participant. In such case,
the deviation will be reported to the sponsor as soon as possible.
Query!
Trial website
https://clinicaltrials.gov/ct2/show/NCT03075722
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
0
0
Query!
Address
0
0
Query!
Country
0
0
Query!
Phone
0
0
Query!
Fax
0
0
Query!
Email
0
0
Query!
Contact person for public queries
Name
0
0
Query!
Address
0
0
Query!
Country
0
0
Query!
Phone
0
0
Query!
Fax
0
0
Query!
Email
0
0
Query!
Contact person for scientific queries
Summary Results
For IPD and results data, please see
https://clinicaltrials.gov/ct2/show/NCT03075722
Download to PDF